2026-04-30T09:11:27Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/143192025-05-08T15:30:44Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19608

00925njm 22002777a 4500 dc Nicolay, Nathalie author Innocenti, Francesco author Beauté, Julien author Učakar, Veronika author Grgič Vitek, Marta author Poukka, Eero author Hannila-Handelberg, Tuula author Gauci, Charmaine author Melillo, Tanya author Georgakopoulou, Theano author Jarkovsky, Jiri author Slezák, Pavel author Delgado-Sanz, Concepcion author Olmedo-Lucerón, Carmen author Suija, Heleene author Liausediene, Rasa author O'Lorcain, Piaras author Murphy, Niamh author Peralta-Santos, André author Casaca, Pedro author Gregoriou, Ioanna author Bundle, Nick author Spiteri, Gianfranco author Ravasi, Giovanni author 2021-12 Prioritisation of elderly people in COVID-19 vaccination campaigns aimed at reducing severe outcomes in this group. Using EU/EEA surveillance and vaccination uptake, we estimated the risk ratio of case, hospitalisation and death notifications in people 80 years and older compared with 25-59-year-olds. Highest impact was observed for full vaccination uptake 80% or higher with reductions in notification rates of cases up to 65% (IRR: 0.35; 95% CI: 0.13-0.99), hospitalisations up to 78% (IRR: 0.22; 95% CI: 0.13-0.37) and deaths up to 84% (IRR: 0.16; 95% CI: 0.13-0.20). Euro Surveill 2021 Dec;26(48):2101030. 10.2807/1560-7917.ES.2021.26.48.2101030 1560-7917 1560-7917 Euro Surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 34857068 http://hdl.handle.net/20.500.12105/14319 COVID-19 Health impact assessment Mass vaccination Vaccination uptake Initial assessment of the COVID-19 vaccination's impact on case numbers, hospitalisations and deaths in people aged 80 years and older, 15 EU/EEA countries, December 2020 to May 2021